跳至主要内容
临床试验/NCT00444821
NCT00444821终止不适用

Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL)

Medtronic Cardiovascular65 个研究点 分布在 1 个国家目标入组 728 人开始时间: 2005年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
728
试验地点
65
主要终点
Number of Subjects That Experienced Rupture or Aneurysm Related Death

研究概览

简要总结

The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 40 to 90 years of age
  • Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use
  • Maximum aneurysm diameter of 4-5cm
  • If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion
  • Patient is willing and able to comply with the specified follow-up evaluation
  • Life expectancy at least 3 years

排除标准

  • Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use
  • Known co-existing condition with a life expectancy of less than 3 years
  • Major surgical or interventional procedure (vascular and/or non-vascular)within 30 days prior to study enrollment
  • Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before.
  • Planned conduit procedure for introduction of endograft

结局指标

主要结局

Number of Subjects That Experienced Rupture or Aneurysm Related Death

时间窗: 3 years

次要结局

  • Aneurysm Growth >0.5 cm(1 year)
  • Secondary Endovascular Procedures Between the 30-day Post Treatment and 3-year Follow-up(study termination)

研究者

发起方
Medtronic Cardiovascular
申办方类型
Industry
责任方
Sponsor

研究点 (65)

Loading locations...

相似试验